In our study, BRCA2 mutations were marginally more common than BRCA1 mutations (BRCA2—1.4% vs. BRCA1—1.2%), and we saw an overall 2.7% prevalence of the mutated BRCA1/2 alleles in Polish women with DCIS. The gene discussed is BRCA2; the disease is ductal breast carcinoma in situ.